z-logo
open-access-imgOpen Access
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
Author(s) -
Yoshihiro Uchino,
Daisuke Muroya,
Munehiro Yoshitomi,
Shigeki Shichijo,
Akira Yamada,
Tetsuro Sasada,
Teppei Yamada,
Koji Okuda,
Kyogo Itoh,
Shigeru Yutani
Publication year - 2020
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2020.2201
Subject(s) - vaccination , medicine , pancreatic cancer , immune system , immunology , peptide vaccine , cancer , antigen , oncology , epitope

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom